Related Experiment Video

Updated: Nov 10, 2025

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
07:56

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis

Published on: May 5, 2023

570

Blood viscosity of COVID-19 patient: a preliminary report

Beuy Joob1, Viroj Wiwanitkit2

  • 1Sanitation 1 Medical Academic Center Bangkok, Thailand.

American Journal of Blood Research
|April 2, 2021
PubMed

Insights

This study found that increased blood viscosity is common in patients with COVID-19, potentially contributing to thrombohemostatic issues. Further research is needed to understand this link between COVID-19 and blood viscosity.

Area of Science:

  • Hematology
  • Virology
  • Cardiovascular Science

Background:

  • COVID-19, a global health crisis, is associated with various hematological alterations.
  • Thrombosis is a significant complication in COVID-19 patients, potentially linked to endothelial dysfunction, platelet activation, increased blood viscosity, and disturbed blood flow.
  • Changes in blood viscosity in COVID-19 patients are recognized but not extensively documented.

Purpose of the Study:

  • To investigate and report preliminary data on blood viscosity measurements in patients diagnosed with COVID-19.
  • To explore the potential association between altered blood viscosity and thrombohemostatic complications in COVID-19.

Main Methods:

  • Preliminary assessment of blood viscosity.
  • Inclusion of 41 patients diagnosed with COVID-19.
  • Estimation of blood viscosity values at high and low shear rates.

Main Results:

  • Preliminary data indicate elevated blood viscosity in COVID-19 patients.
  • Estimated blood viscosity values were 72.4 ± 18.6 for high shear rates and 18.2 ± 2.2 for low shear rates.
  • Increased blood viscosity was detected in the studied COVID-19 cohort.

Conclusions:

  • Preliminary findings suggest that increased blood viscosity is present in COVID-19 patients.
  • Elevated blood viscosity may be associated with thrombohemostatic problems in the context of COVID-19.
  • Further investigation is warranted to elucidate the role of blood viscosity in COVID-19 pathophysiology.

Keywords:
COVID-19bloodviscosity

More Related Videos

Meso-Scale Particle Image Velocimetry Studies of Neurovascular Flows In Vitro08:00

Meso-Scale Particle Image Velocimetry Studies of Neurovascular Flows In Vitro

Published on: December 3, 2018

8.6K
Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care14:28

Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care

Published on: May 10, 2024

1.9K

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
12.3K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
1.2K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
102
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
1.9K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
409
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
505